Article
Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis.
BioMed research international - 1 Jan 2020
Zhang Ningning, Ouyang Yushu, Chang Jianlan, Liu Ping, Tian Xiangyang, Yu Junyan
Abstract excerpt
BACKGROUND: Platinum-based chemotherapy plays an antitumor role by damaging DNA. X-ray repair crosscomplementing protein 1 (XRCC1) participates in DNA repair and thus affects the sensitivity to platinum drugs. Two polymorphisms of XRCC1, rs25487 (Arg399Gln) and rs1799782 (Arg194Trp), have been widely studied for the association with clinical outcomes of platinum-based chemotherapy in Asian patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
